Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ONS 44th Annual Congress /
Benefits of cannabis legalisation to patients and oncology professionals

11th - 14th Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.05.19
Views: 582

Eloise Theisen - Radicle Health, Walnut Creek, USA

Eloise Theisen speaks to ecancer at ONS 2019 about the potential benefits of cannabis legalisation to both patients and oncology professionals.

Eloise outlines some of the usual arguments made for and against cannabis legalisation, as well as the past and current laws regarding cannabis use in the United States. She also debunks some of the common misunderstandings around this topic.

She explains that there are already cancer patients that are using cannabis, and that legalisation is likely to create a safer environment to provide it to patients. She argues that nurses could be provided with more thorough guidelines and training, in order to provide suitable patients with appropriate resources and products.

Eloise concludes that oncology professionals need to destigmatise cannabis and start treating it as a medicine, and that she hopes for federal de-scheduling in the future.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation